Despite being virtually eradicated in developed countries, Tuberculosis (TB) is one of the world’s leading causes of death, and a forefront healthcare issue for the developing world.
TB kills 1.5 million people every year and it’s believed that 3 million go undiagnosed, making disease diagnosis a central part of the strategy to fight TB, along with vaccine and medicine delivery. Currently, diagnosing TB requires a complicated procedure, including blood tests and examination of chest x-rays, which requires highly-trained medical personnel.
The ANCON Medical NBT device is the ideal weapon to fight a disease like TB, allowing for mass screenings by use of a simple breath test that can be administered by non-medical staff and volunteers, with results in less than one hour. Further research into the TB’s biomarker is the next step, and would make take the NBT device an indispensable tool for screening for the disease.